124 related articles for article (PubMed ID: 34761752)
1. Resolving hepatic fibrosis
Ren L; Li J; Liu L; Wu W; Zhao D; Zhang K; Xin X; Yang L; Yin L
Biomater Sci; 2021 Dec; 9(24):8259-8269. PubMed ID: 34761752
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
[TBL] [Abstract][Full Text] [Related]
3. Sequential delivery for hepatic fibrosis treatment based on carvedilol loaded star-like nanozyme.
Lu Q; Zhou Y; Xu M; Liang X; Jing H; Wang X; Li N
J Control Release; 2022 Jan; 341():247-260. PubMed ID: 34826531
[TBL] [Abstract][Full Text] [Related]
4. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
[TBL] [Abstract][Full Text] [Related]
5. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
6. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
7. Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase.
Shajari S; Laliena A; Heegsma J; Tuñón MJ; Moshage H; Faber KN
J Pineal Res; 2015 Oct; 59(3):391-401. PubMed ID: 26308880
[TBL] [Abstract][Full Text] [Related]
8. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
[TBL] [Abstract][Full Text] [Related]
9. ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis.
Shen M; Guo M; Wang Z; Li Y; Kong D; Shao J; Tan S; Chen A; Zhang F; Zhang Z; Zheng S
Int Immunopharmacol; 2020 Aug; 85():106637. PubMed ID: 32512269
[TBL] [Abstract][Full Text] [Related]
10. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.
Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA
Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
13. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
14. Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities.
Zhang J; Shen H; Xu J; Liu L; Tan J; Li M; Xu N; Luo S; Wang J; Yang F; Tang J; Li Q; Wang Y; Yu L; Yan Z
ACS Nano; 2020 May; 14(5):6305-6322. PubMed ID: 32378877
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
Li X; Wang X; Han C; Wang X; Xing G; Zhou L; Li G; Niu Y
Free Radic Biol Med; 2013 Jul; 60():168-76. PubMed ID: 23459070
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
[TBL] [Abstract][Full Text] [Related]
17. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
[TBL] [Abstract][Full Text] [Related]
19. Tetramethylpyrazine ameliorates hepatic fibrosis through autophagy-mediated inflammation.
Hu Z; Su H; Zeng Y; Lin C; Guo Z; Zhong F; Jiang K; Yuan G; He S
Biochem Cell Biol; 2020 Jun; 98(3):327-337. PubMed ID: 32383631
[TBL] [Abstract][Full Text] [Related]
20. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
